Contribution regulations
Aims and Scope
To
accumulate clinical cases related to nuclear medicine diagnosis and nuclear
medicine treatment and to utilize it for clinical, educational purposes.
To
spread understanding of nuclear medicine to doctors, medical radiology
technicians, nurses, students, etc.
All Authors
All
manuscripts are double-blind peer reviewed by two reviewers of editorial
boards.
Double posts posted in other
peer-reviewed magazines are prohibited in principle.
Final
acceptance or rejection rests with the Editorial Board.
Any
reproduced figure or table must include permission from its copyright holders.
In
using Figures and tables published in proceedings of Nuclear Medicine Case Conference
(ISSN / ISBN / CODEN: 0910-2213), you may use the prepared permission
form.
Authors
are responsible for the linguistic accuracy of their manuscripts and should
seek advice from English experts.
The copyright of the paper is
attributed to the author.
Editorial Reviews
Selection
criteria for submitted manuscripts are usefulness in practice and education in
nuclear medicine.
Reviewers' comments can be English or
Japanese.
The
consistency of the logic of the submitted manuscript is checked.
Publication Fee
The publication fee of the adopted
manuscript is free.
Ethics
Informed consent from patients and conflicts of interest
are described in the paper.
Category
1)
Case Reports
Manuscript form
(Case Reports).docx. Click the icon.
Case reports that are expected to have
educational effects in clinical nuclear medicine. Case report should be no more
than 1000 words (excluding references), with generally no more than 10
references.
Case reports consist of title, authors,
authors affiliations, abstract (within 250 words), keywords (within 6 words), Introduction,
case report, discussion, conclusion,
references.
There shall be no more than five
figures and tables. Concise legends of the figures, titles of the tables are
necessary.
A statement on informed consent and
conflict of interest are needed.
2)
Images of keeping
in mind
Manuscript form (Images of keeping in mind).docx. Click the icon.
From the viewpoint of nuclear medicine,
present images that are impressive, interesting, and / or educational. Those
that do not have definite diagnosis are also accepted, with generally no more
than 10 references.
Images to keep in mind consists of
title, authors, authors affiliations, abstract (within 250 words), keywords
(within 6 words ), figure(s), references (no more than 10 references).
There are no more than five figures,
which must be mentioned in detail in each Legend, but it must be within a total
of 800 words. Reference citations should appear in the legends.
A statement on informed consent and
conflict of interest are needed.
Submission
After downloading the Microsoft Word
manuscript form, all submitted manuscripts need to fill in all the necessary
information in the submitting, including the layout of the figures and tables.
Save your file in docx fomat.
Please send the completed manuscript to
jacnm2018@gmail.com.
Use 12-point Time.
Use italics for emphasis.
Initially use the word in full,
followed by the abbreviation in parentheses.
Isotope notation should employ a
superscript.
For example, Tc-99m should appear as “99mTc”.
All measurements must be given in
Systeme International (SI) units.
References
Reference
citations in the text should be identified by numbers in square brackets.
For example
This result was
found by Uemura et al. [2].
This phenomenon
was reported by some investigators [4-6, 8].
The list of cited documents is a document cited in the
text and must be a document that has already been published or has been decided
to be published. Personal correspondence and unpublished data will be mentioned
only in sentences.
Items in the list are sequentially numbered.
When using citation management software, use EJNMMI style.
For all authors up to six people are listed, and for more than six people it is
abbreviated as et al.
For example,
Journal
Articles
Sathekge M, Knoesen O, Meckel M, Modiselle M, Vorster M, Marx S. 213Bi-PSMA-617 targeted alpha-radionuclide therapy
in metastatic castration-resistant prostate cancer. Eur
J Nucl Med Mol Imaging.
2017;44(6):1099–100.
https://doi.org/10.1007/s00259-017-3657-9.
Book
Schlumberger
M, Pacini F. Thyroid tumors. 3rd ed. Paris: Editions
Nucleon; 2006.
Haq M, Harmer C. Non-surgical management of
thyroid cancer. In: Mazzaferri EL, Harmer C, Mallick U, Kendall-Taylor P, editors. Practical management of
thyroid cancer. London: Springer-Verlag; 2006. p.
171–91.
December,
2018